Press Releases CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
15.94 ^USD	+0.69%		+2.84%	+32.83%

May. 17	Craig-Hallum Adjusts Price Target on CareDx to $22 From $15, Maintains Buy Rating	MT
May. 16	Study Shows CareDx, Inc.?s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies	May. 16	BU
CareDx : 2024 Proxy Statement	May. 13	PU
CareDx: Q1 Earnings Snapshot	May. 09	AQ
CareDx Reports First Quarter 2024 Results	May. 09	BU
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	May. 03	BU
CareDx to Report First Quarter 2024 Financial Results	Apr. 29	BU
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	Apr. 19	BU
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer	Apr. 16	BU
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting	Apr. 09	BU
CareDx Appoints Bryan Riggsbee to Its Board of Directors	Mar. 11	BU
CareDx : Appoints Bryan Riggsbee to Its Board of Directors - Form 8-K	Mar. 11	PU
CareDx : Corporate Presentation February 2024	Mar. 01	PU
CareDx: Q4 Earnings Snapshot	Feb. 28	AQ
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	BU
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference	Feb. 27	BU
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results	Feb. 21	BU
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings	Feb. 21	BU
Jury Rules in Favor of Natera in Patent Infringement Lawsuit against CareDx, Awards $96.3 Million in Damages to Natera in Lost Profits and Past Royalties	Jan. 30	AQ
CareDx Issues Statement in Patent Infringement Case	Jan. 26	BU
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium	Jan. 11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CareDx, Inc

Equities

CDNA

US14167L1035

Press Releases

Filters